Salvum Labsp. z o.o.

Wholesale of other food, including fish, crustaceans and molluscs

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2025-04-01
Share capital
10 000,00 PLN
Activity description

Salvum Lab supplies medical devices, food supplements, and dietary foods for special medical purposes. Products under the Protego and Garda brands include magnesium supplements, electrolytes, collagen products, and lozenges for cough and hoarseness.

Registered address
ul. Jana Sobieskiego 53, 58-500 Jelenia Góra, Poland
Website
salvum.plWebsite active
Email
Email address current
Phone
Social media
Electronic delivery address
AE:PL-59719-75528-JDWWS-28

Financials

Revenue history (in k)

Financial insight

  • companies.financials.estonianCitCertain

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 3.74mMedianUSD 1.01mAverageUSD 11.80m
Net profit
This companyUSD 325.97kMedianUSD 15.85kAverageUSD 809.27k
Operating costs
This companyUSD 3.32mMedianUSD 986.22kAverageUSD 10.74m
Assets
This companyUSD 1.83mMedianUSD 427.38kAverageUSD 4.93m

Bank accounts

Registered as a VAT taxpayer on 2010-12-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

TypeAmount
Buildings and premises
PLN 150.7K

MSiG notices

Publication dateEvent
Apr 28, 2025Transformation registered

Public aid

26 public aid cases recorded, with a total value of $342,485.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$18,081
De minimis aid (in accordance with Commission Regulation 2023/2831)
$52,778
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$28,049

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Artur Marek Lewandowski – Management Board Member
Dariusz Jacek Lewandowski – Management Board Member
Stanisław Jerzy Zawadzki – Management Board Member
Krzysztof Kowaleczko – Management Board Member

Manner of representation

If a multi-member management board is appointed, two members of the management board acting jointly or the President of the Management Board acting independently are authorized to make declarations of will and sign on behalf of the company.

Ownership

OwnerSharesShare valueStake
Krzysztof Kowaleczko (51)
53$715.8326.5%
Artur Marek Lewandowski (54)
53$715.8326.5%
Dariusz Jacek Lewandowski (50)
53$715.8326.5%
Stanisław Jerzy Zawadzki (57)
41$553.7520.5%

Artur Marek Lewandowski and Dariusz Jacek Lewandowski hold a combined 53% – the ownership structure indicates family control.

Beneficial owners

Person

Competitors

Name
Pharmovit Dystrybucjasp. z o.o.
Przedsiębiorstwo Produkcyjno-Handlowo-Usługowe Paksol Leszek i Małgorzata Witczaksp. j.
Calfertsp. z o.o.
DR Vitasp. z o.o.
Medlab-Productssp. z o.o.
PK Components sp. z o.o.sp. k.
Formedicsp. z o.o.
Activepharm Labssp. z o.o.
Medicossp. z o.o.
New Nordic Healthbrands Polskasp. z o.o.

FAQ

Last updated: 2026-05-07